UPK2 and urothelial carcinoma: CTC detection in BC was first reported in 2000 by Lu et al., when they published a method for CTC detection in peripheral blood of patients with urothelial carcinoma using nested reverse transcription-PCR assay for UPK2 (Uroplakin II) [75].